Global ECG Market Research and Analysis, 2014-2020
MARKET INSIGHTS
Global ECG market is expected to grow at a CAGR of 6.5% for the forecasted period of 2015-2020. The market is segmented on the basis of segments, type of lead and end users. EGG segments include resting systems, stress systems and Holter monitor systems. The market by lead type includes single lead, 3-6 leads and 12 leads. End users include hospitals, clinics, diagnostic centres and home care. ECG market is majorly driven growing population with cardiovascular diseases. CVDs are responsible for over 3 million diseases annually. CVDs include coronary heart diseases, stroke, hypertensive heart diseases, inflammatory heart diseases, rheumatoid heart diseases and others. Coronary heart diseases are the major disease when it comes to death per year followed by strokes. The prevalence and incidence rate of heart diseases are on a rise; especially in major emerging countries such as India, China and Japan. Changing lifestyle are playing a major part as the main cause for cardiovascular diseases. This has led to more number of people opting for diagnostic tests. ECG is the first level of test to detect CVDs. Portable ECGs and point of care solution are also gaining popularity. It is majorly due to the convenience for the patients, who in most of the cases are elderly. A majority of adults over 50 suffer from one or other kind of heart ailments. Hence, point of care solution provide a certain amount of convenience and helps them in reducing the cost of hospital stay.
Regionally, North America is the leading market. North America has large population of over fifty. CVDs are major disease in NA. Also, easy availability and reimbursements also drive the North American Market. Canada has one of the best healthcare system when it comes to CVDs. Europe will be the second largest market and Asia Pacific will have the highest market growth.
Global ECG market is expected to grow at a CAGR of 6.5% for the forecasted period of 2015-2020. The market is segmented on the basis of segments, type of lead and end users. EGG segments include resting systems, stress systems and Holter monitor systems. The market by lead type includes single lead, 3-6 leads and 12 leads. End users include hospitals, clinics, diagnostic centres and home care. ECG market is majorly driven growing population with cardiovascular diseases. CVDs are responsible for over 3 million diseases annually. CVDs include coronary heart diseases, stroke, hypertensive heart diseases, inflammatory heart diseases, rheumatoid heart diseases and others. Coronary heart diseases are the major disease when it comes to death per year followed by strokes. The prevalence and incidence rate of heart diseases are on a rise; especially in major emerging countries such as India, China and Japan. Changing lifestyle are playing a major part as the main cause for cardiovascular diseases. This has led to more number of people opting for diagnostic tests. ECG is the first level of test to detect CVDs. Portable ECGs and point of care solution are also gaining popularity. It is majorly due to the convenience for the patients, who in most of the cases are elderly. A majority of adults over 50 suffer from one or other kind of heart ailments. Hence, point of care solution provide a certain amount of convenience and helps them in reducing the cost of hospital stay.
Regionally, North America is the leading market. North America has large population of over fifty. CVDs are major disease in NA. Also, easy availability and reimbursements also drive the North American Market. Canada has one of the best healthcare system when it comes to CVDs. Europe will be the second largest market and Asia Pacific will have the highest market growth.
REPORT SUMMARY
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
1.2.4. EXCEPTIONS
MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. GAP ANALYSIS
2.3. HISTORICAL ANALYSIS
2.4. CURRENT MARKET TRENDS
2.5. ANALYST INSIGHT
2.5.1. KEY FINDINGS
2.5.2. RECOMMENDATION
2.5.3. CONCLUSION
2.6. REGULATION
2.6.1. TAX LAWS
2.6.1.1. UNITED STATES
2.6.1.2. EUROPEAN UNION
2.6.1.3. CHINA
2.6.1.4. INDIA
2.6.1.5. REST OF THE WORLD
2.6.2. DRUGS AND DEVICE REGULATIONS
2.6.2.1. UNITED STATES
2.6.2.2. EUROPEAN UNION
2.6.2.3. CHINA
2.6.2.4. INDIA
2.6.2.5. REST OF THE WORLD
MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. HIGH PREVALENCE OF CARDIOVASCULAR DISEASES SPECIALLY IN EMERGING COUNTRIES
3.1.2. RISING AGEING POPULATION IN DEVELOPED NATION
3.1.3. DEVELOPMENT OF PORTABLE AND POINT OF CARE SOLUTION FOR CVDS
3.1.4. FAVOURABLE GOVERNMENT REGULATIONS
3.2. RESTRAINT
3.2.1. LIMITED MARKET CAPABILITIES IN UNDERDEVELOPED MARKETS
3.2.2. REIMBURSEMENTS
3.2.3. HIGH PRICE
3.3. OPPORTUNITY
3.3.1. EMERGING MARKETS
3.3.2. LIMITED ENTRY BARRIERS FOR NEW COMPANIES
PARENT MARKET ANALYSIS
MARKET SEGMENTATION
5.1. GLOBAL ECG DEVICES BY END USERS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1. GLOBAL ECG DEVICES BY HOSPITALS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.2. GLOBAL ECG DEVICES BY CLINICS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.3. GLOBAL ECG DEVICES BY DIAGNOSTIC CENTRES MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.4. GLOBAL ECG DEVICES BY HOME CARE MARKET RESEARCH AND ANALYSIS, 2014-2020
5.2. GLOBAL ECG DEVICES BY PRODUCT MARKET RESEARCH AND ANALYSIS, 2014-2020
5.2.1. GLOBAL RESTING ECG SYSTEMS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.2.2. GLOBAL STRESS ECG SYSTEMS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.2.3. GLOBAL HOLTER MONITORS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.3. GLOBAL ECG DEVICES BY LEAD TYPE MARKET RESEARCH AND ANALYSIS, 2014-2020
5.3.1. GLOBAL SINGLE LEAD TYPE ECG DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
5.3.2. GLOBAL 3-6 LEAD TYPE ECG DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
5.3.3. GLOBAL 12 LEAD TYPE ECG DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
5.3.4. GLOBAL OTHER LEAD TYPE DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
COMPETITIVE LANDSCAPE
6.1. MARKET SHARE ANALYSIS
6.2. KEY COMPANY ANALYSIS
REGIONAL ANALYSIS
7.1. NORTH AMERICAN MARKET RESEARCH AND ANALYSIS, 2014-2020
7.1.1. UNITED STATES MARKET RESEARCH AND ANALYSIS, 2014-2020
7.1.2. CANADA MARKET RESEARCH AND ANALYSIS, 2014-2020
7.2. EUROPEAN MARKET RESEARCH AND ANALYSIS, 2014-2020
7.2.1. WESTERN EUROPE MARKET RESEARCH AND ANALYSIS, 2014-2020
7.2.2. ROE MARKET RESEARCH AND ANALYSIS, 2014-2020
7.3. ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2014-2020
7.3.1. INDIA MARKET RESEARCH AND ANALYSIS, 2014-2020
7.3.2. CHINA MARKET RESEARCH AND ANALYSIS, 2014-2020
7.3.3. JAPAN MARKET RESEARCH AND ANALYSIS, 2014-2020
7.3.4. ROAPAC MARKET RESEARCH AND ANALYSIS, 2014-2020
7.4. REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2014-2020
COMPANY PROFILES
8.1. BIONET
8.1.1. INTRODUCTION
8.1.2. PRODUCT PORTFOLIO
8.1.3. RECENT ACTIVITIES
8.1.4. SWOT
8.2. MIDMARK
8.2.1. INTRODUCTION
8.2.2. PRODUCT PORTFOLIO
8.2.3. RECENT ACTIVITIES
8.2.4. SWOT
8.3. CARDIAC SCIENCE CORPORATION
8.3.1. INTRODUCTION
8.3.2. PRODUCT PORTFOLIO
8.3.3. RECENT ACTIVITIES
8.3.4. SWOT
8.4. GE HEALTHCARE
8.4.1. INTRODUCTION
8.4.2. PRODUCT PORTFOLIO
8.4.3. RECENT ACTIVITIES
8.4.4. SWOT
8.5. PHILIPS
8.5.1. INTRODUCTION
8.5.2. PRODUCT PORTFOLIO
8.5.3. RECENT ACTIVITIES
8.5.4. SWOT
8.6. SCHILLER
8.6.1. INTRODUCTION
8.6.2. PRODUCT PORTFOLIO
8.6.3. RECENT ACTIVITIES
8.6.4. SWOT
8.7. CARDIONET
8.7.1. INTRODUCTION
8.7.2. PRODUCT PORTFOLIO
8.7.3. RECENT ACTIVITIES
8.7.4. SWOT
8.8. WELCH ALLYN.
8.8.1. INTRODUCTION
8.8.2. PRODUCT PORTFOLIO
8.8.3. RECENT ACTIVITIES
8.8.4. SWOT
8.9. SPACELABS HEALTHCARE
8.9.1. INTRODUCTION
8.9.2. PRODUCT PORTFOLIO
8.9.3. RECENT ACTIVITIES
8.9.4. SWOT
8.10. CUSTO MED GMBH
8.10.1. INTRODUCTION
8.10.2. PRODUCT PORTFOLIO
8.10.3. RECENT ACTIVITIES
8.10.4. SWOT
8.11. CARDIOLINE S.P.A
8.11.1. INTRODUCTION
8.11.2. PRODUCT PORTFOLIO
8.11.3. RECENT ACTIVITIES
8.11.4. SWOT
8.12. MORTARA INSTRUMENT
8.12.1. INTRODUCTION
8.12.2. PRODUCT PORTFOLIO
8.12.3. RECENT ACTIVITIES
8.12.4. SWOT
8.13. ALLENGERS MEDICAL SYSTEMS LTD.
8.13.1. INTRODUCTION
8.13.2. PRODUCT PORTFOLIO
8.13.3. RECENT ACTIVITIES
8.13.4. SWOT
8.14. ECCOSUR SA
8.14.1. INTRODUCTION
8.14.2. PRODUCT PORTFOLIO
8.14.3. RECENT ACTIVITIES
8.14.4. SWOT
8.15. NIHON KOHDEN CORPORATION
8.15.1. INTRODUCTION
8.15.2. PRODUCT PORTFOLIO
8.15.3. RECENT ACTIVITIES
8.16. NEXUS LIFECARE
8.16.1. INTRODUCTION
8.16.2. PRODUCT PORTFOLIO
8.16.3. RECENT ACTIVITIES
8.16.4. SWOT
8.17. MINDRAY MEDICAL INTERNATIONAL LIMITED
8.17.1. INTRODUCTION
8.17.2. PRODUCT PORTFOLIO
8.17.3. RECENT ACTIVITIES
8.17.4. SWOT
8.18. JOHNSON AND JOHNSON
8.18.1. INTRODUCTION
8.18.2. PRODUCT PORTFOLIO
8.18.3. RECENT ACTIVITIES
8.18.4. SWOT
8.19. EDUTEK INSTRUMENTATION
8.19.1. INTRODUCTION
8.19.2. PRODUCT PORTFOLIO
8.19.3. RECENT ACTIVITIES
8.19.4. SWOT
8.20. BRENTWOOD MIDMARK
8.20.1. INTRODUCTION
8.20.2. PRODUCT PORTFOLIO
8.20.3. RECENT ACTIVITIES
8.20.4. SWOT
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
1.2.4. EXCEPTIONS
MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. GAP ANALYSIS
2.3. HISTORICAL ANALYSIS
2.4. CURRENT MARKET TRENDS
2.5. ANALYST INSIGHT
2.5.1. KEY FINDINGS
2.5.2. RECOMMENDATION
2.5.3. CONCLUSION
2.6. REGULATION
2.6.1. TAX LAWS
2.6.1.1. UNITED STATES
2.6.1.2. EUROPEAN UNION
2.6.1.3. CHINA
2.6.1.4. INDIA
2.6.1.5. REST OF THE WORLD
2.6.2. DRUGS AND DEVICE REGULATIONS
2.6.2.1. UNITED STATES
2.6.2.2. EUROPEAN UNION
2.6.2.3. CHINA
2.6.2.4. INDIA
2.6.2.5. REST OF THE WORLD
MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. HIGH PREVALENCE OF CARDIOVASCULAR DISEASES SPECIALLY IN EMERGING COUNTRIES
3.1.2. RISING AGEING POPULATION IN DEVELOPED NATION
3.1.3. DEVELOPMENT OF PORTABLE AND POINT OF CARE SOLUTION FOR CVDS
3.1.4. FAVOURABLE GOVERNMENT REGULATIONS
3.2. RESTRAINT
3.2.1. LIMITED MARKET CAPABILITIES IN UNDERDEVELOPED MARKETS
3.2.2. REIMBURSEMENTS
3.2.3. HIGH PRICE
3.3. OPPORTUNITY
3.3.1. EMERGING MARKETS
3.3.2. LIMITED ENTRY BARRIERS FOR NEW COMPANIES
PARENT MARKET ANALYSIS
MARKET SEGMENTATION
5.1. GLOBAL ECG DEVICES BY END USERS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1. GLOBAL ECG DEVICES BY HOSPITALS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.2. GLOBAL ECG DEVICES BY CLINICS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.3. GLOBAL ECG DEVICES BY DIAGNOSTIC CENTRES MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.4. GLOBAL ECG DEVICES BY HOME CARE MARKET RESEARCH AND ANALYSIS, 2014-2020
5.2. GLOBAL ECG DEVICES BY PRODUCT MARKET RESEARCH AND ANALYSIS, 2014-2020
5.2.1. GLOBAL RESTING ECG SYSTEMS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.2.2. GLOBAL STRESS ECG SYSTEMS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.2.3. GLOBAL HOLTER MONITORS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.3. GLOBAL ECG DEVICES BY LEAD TYPE MARKET RESEARCH AND ANALYSIS, 2014-2020
5.3.1. GLOBAL SINGLE LEAD TYPE ECG DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
5.3.2. GLOBAL 3-6 LEAD TYPE ECG DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
5.3.3. GLOBAL 12 LEAD TYPE ECG DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
5.3.4. GLOBAL OTHER LEAD TYPE DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
COMPETITIVE LANDSCAPE
6.1. MARKET SHARE ANALYSIS
6.2. KEY COMPANY ANALYSIS
REGIONAL ANALYSIS
7.1. NORTH AMERICAN MARKET RESEARCH AND ANALYSIS, 2014-2020
7.1.1. UNITED STATES MARKET RESEARCH AND ANALYSIS, 2014-2020
7.1.2. CANADA MARKET RESEARCH AND ANALYSIS, 2014-2020
7.2. EUROPEAN MARKET RESEARCH AND ANALYSIS, 2014-2020
7.2.1. WESTERN EUROPE MARKET RESEARCH AND ANALYSIS, 2014-2020
7.2.2. ROE MARKET RESEARCH AND ANALYSIS, 2014-2020
7.3. ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2014-2020
7.3.1. INDIA MARKET RESEARCH AND ANALYSIS, 2014-2020
7.3.2. CHINA MARKET RESEARCH AND ANALYSIS, 2014-2020
7.3.3. JAPAN MARKET RESEARCH AND ANALYSIS, 2014-2020
7.3.4. ROAPAC MARKET RESEARCH AND ANALYSIS, 2014-2020
7.4. REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2014-2020
COMPANY PROFILES
8.1. BIONET
8.1.1. INTRODUCTION
8.1.2. PRODUCT PORTFOLIO
8.1.3. RECENT ACTIVITIES
8.1.4. SWOT
8.2. MIDMARK
8.2.1. INTRODUCTION
8.2.2. PRODUCT PORTFOLIO
8.2.3. RECENT ACTIVITIES
8.2.4. SWOT
8.3. CARDIAC SCIENCE CORPORATION
8.3.1. INTRODUCTION
8.3.2. PRODUCT PORTFOLIO
8.3.3. RECENT ACTIVITIES
8.3.4. SWOT
8.4. GE HEALTHCARE
8.4.1. INTRODUCTION
8.4.2. PRODUCT PORTFOLIO
8.4.3. RECENT ACTIVITIES
8.4.4. SWOT
8.5. PHILIPS
8.5.1. INTRODUCTION
8.5.2. PRODUCT PORTFOLIO
8.5.3. RECENT ACTIVITIES
8.5.4. SWOT
8.6. SCHILLER
8.6.1. INTRODUCTION
8.6.2. PRODUCT PORTFOLIO
8.6.3. RECENT ACTIVITIES
8.6.4. SWOT
8.7. CARDIONET
8.7.1. INTRODUCTION
8.7.2. PRODUCT PORTFOLIO
8.7.3. RECENT ACTIVITIES
8.7.4. SWOT
8.8. WELCH ALLYN.
8.8.1. INTRODUCTION
8.8.2. PRODUCT PORTFOLIO
8.8.3. RECENT ACTIVITIES
8.8.4. SWOT
8.9. SPACELABS HEALTHCARE
8.9.1. INTRODUCTION
8.9.2. PRODUCT PORTFOLIO
8.9.3. RECENT ACTIVITIES
8.9.4. SWOT
8.10. CUSTO MED GMBH
8.10.1. INTRODUCTION
8.10.2. PRODUCT PORTFOLIO
8.10.3. RECENT ACTIVITIES
8.10.4. SWOT
8.11. CARDIOLINE S.P.A
8.11.1. INTRODUCTION
8.11.2. PRODUCT PORTFOLIO
8.11.3. RECENT ACTIVITIES
8.11.4. SWOT
8.12. MORTARA INSTRUMENT
8.12.1. INTRODUCTION
8.12.2. PRODUCT PORTFOLIO
8.12.3. RECENT ACTIVITIES
8.12.4. SWOT
8.13. ALLENGERS MEDICAL SYSTEMS LTD.
8.13.1. INTRODUCTION
8.13.2. PRODUCT PORTFOLIO
8.13.3. RECENT ACTIVITIES
8.13.4. SWOT
8.14. ECCOSUR SA
8.14.1. INTRODUCTION
8.14.2. PRODUCT PORTFOLIO
8.14.3. RECENT ACTIVITIES
8.14.4. SWOT
8.15. NIHON KOHDEN CORPORATION
8.15.1. INTRODUCTION
8.15.2. PRODUCT PORTFOLIO
8.15.3. RECENT ACTIVITIES
8.16. NEXUS LIFECARE
8.16.1. INTRODUCTION
8.16.2. PRODUCT PORTFOLIO
8.16.3. RECENT ACTIVITIES
8.16.4. SWOT
8.17. MINDRAY MEDICAL INTERNATIONAL LIMITED
8.17.1. INTRODUCTION
8.17.2. PRODUCT PORTFOLIO
8.17.3. RECENT ACTIVITIES
8.17.4. SWOT
8.18. JOHNSON AND JOHNSON
8.18.1. INTRODUCTION
8.18.2. PRODUCT PORTFOLIO
8.18.3. RECENT ACTIVITIES
8.18.4. SWOT
8.19. EDUTEK INSTRUMENTATION
8.19.1. INTRODUCTION
8.19.2. PRODUCT PORTFOLIO
8.19.3. RECENT ACTIVITIES
8.19.4. SWOT
8.20. BRENTWOOD MIDMARK
8.20.1. INTRODUCTION
8.20.2. PRODUCT PORTFOLIO
8.20.3. RECENT ACTIVITIES
8.20.4. SWOT
LIST OF TABLES
TABLE # 1 GLOBAL ECG DEVICES BY END USERS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 2 GLOBAL ECG DEVICES BY HOSPITALS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 3 GLOBAL ECG DEVICES BY CLINICS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 4 GLOBAL ECG DEVICES BY DIAGNOSTIC CENTERS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 5 GLOBAL ECG DEVICES BY HOME CARE MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 6 GLOBAL ECG DEVICES BY PRODUCT MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 7 GLOBAL RESTING ECG SYSTEMS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 8 GLOBAL STRESS ECG SYSTEMS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 9 GLOBAL HOLTER MONITORS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 10 GLOBAL ECG DEVICES BY LEAD TYPE MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 11 GLOBAL SINGLE LEAD TYPE ECG DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 12 GLOBAL 3-6 LEAD TYPE ECG DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 13 GLOBAL 12 LEAD TYPE ECG DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 14 GLOBAL OTHER LEAD TYPE DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 1 GLOBAL ECG DEVICES BY END USERS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 2 GLOBAL ECG DEVICES BY HOSPITALS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 3 GLOBAL ECG DEVICES BY CLINICS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 4 GLOBAL ECG DEVICES BY DIAGNOSTIC CENTERS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 5 GLOBAL ECG DEVICES BY HOME CARE MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 6 GLOBAL ECG DEVICES BY PRODUCT MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 7 GLOBAL RESTING ECG SYSTEMS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 8 GLOBAL STRESS ECG SYSTEMS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 9 GLOBAL HOLTER MONITORS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 10 GLOBAL ECG DEVICES BY LEAD TYPE MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 11 GLOBAL SINGLE LEAD TYPE ECG DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 12 GLOBAL 3-6 LEAD TYPE ECG DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 13 GLOBAL 12 LEAD TYPE ECG DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 14 GLOBAL OTHER LEAD TYPE DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
LIST OF FIGURES
FIGURE # 1 NORTH AMERICAN MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 2 UNITED STATES MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 3 CANADA MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 4 EUROPEAN MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 5 WESTERN EUROPE MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 6 ROE MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 7 ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 8 INDIA MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 9 CHINA MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 10 JAPAN MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 11 ROAPAC MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 12 REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2014-2020
COMPANIES MENTIONED
1. BIONET
2. MIDMARK
3. CARDIAC SCIENCE CORPORATION
4. GE HEALTHCARE
5. PHILIPS
6. SCHILLER
7. CARDIONET
8. WELCH ALLYN.
9. SPACELABS HEALTHCARE
10. CUSTO MED GMBH
11. CARDIOLINE S.P.A
12. MORTARA INSTRUMENT
13. ALLENGERS MEDICAL SYSTEMS LTD.
14. ECCOSUR SA
15. NIHON KOHDEN CORPORATION
16. NEXUS LIFECARE
17. MINDRAY MEDICAL INTERNATIONAL LIMITED
18. JOHNSON AND JOHNSON
19. EDUTEK INSTRUMENTATION
20. BRENTWOOD MIDMARK
FIGURE # 1 NORTH AMERICAN MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 2 UNITED STATES MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 3 CANADA MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 4 EUROPEAN MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 5 WESTERN EUROPE MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 6 ROE MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 7 ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 8 INDIA MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 9 CHINA MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 10 JAPAN MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 11 ROAPAC MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 12 REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2014-2020
COMPANIES MENTIONED
1. BIONET
2. MIDMARK
3. CARDIAC SCIENCE CORPORATION
4. GE HEALTHCARE
5. PHILIPS
6. SCHILLER
7. CARDIONET
8. WELCH ALLYN.
9. SPACELABS HEALTHCARE
10. CUSTO MED GMBH
11. CARDIOLINE S.P.A
12. MORTARA INSTRUMENT
13. ALLENGERS MEDICAL SYSTEMS LTD.
14. ECCOSUR SA
15. NIHON KOHDEN CORPORATION
16. NEXUS LIFECARE
17. MINDRAY MEDICAL INTERNATIONAL LIMITED
18. JOHNSON AND JOHNSON
19. EDUTEK INSTRUMENTATION
20. BRENTWOOD MIDMARK
